Nuveen Asset Management

Nuveen Asset Management Portfolio holdings

AUM $354B
1-Year Return 34.48%
 

Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.

This Quarter Return
-14.96%
1 Year Return
+34.48%
3 Year Return
+60.43%
5 Year Return
+189.89%
10 Year Return
+390.34%
AUM
$259B
AUM Growth
-$50.1B
Cap. Flow
-$2.37B
Cap. Flow %
-0.92%
Top 10 Hldgs %
21.65%
Holding
3,565
New
266
Increased
1,459
Reduced
1,410
Closed
322

Top Sells

1
BIDU icon
Baidu
BIDU
$302M
2
CSCO icon
Cisco
CSCO
$286M
3
ABBV icon
AbbVie
ABBV
$261M
4
NVDA icon
NVIDIA
NVDA
$210M
5
GM icon
General Motors
GM
$210M

Sector Composition

1 Technology 23.58%
2 Healthcare 13.98%
3 Financials 12.35%
4 Consumer Discretionary 10.53%
5 Industrials 8.28%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
VSTM icon
3326
Verastem
VSTM
$663M
-42,697
Closed -$651K
WVE icon
3327
Wave Life Sciences
WVE
$1.32B
-139,637
Closed -$338K
XBIT icon
3328
XBiotech
XBIT
$89M
-88,400
Closed -$764K
XGN icon
3329
Exagen
XGN
$213M
-17,388
Closed -$142K
XLO icon
3330
Xilio Therapeutics
XLO
$36.3M
-11,284
Closed -$80K
XOMA icon
3331
Xoma
XOMA
$426M
-21,248
Closed -$627K
YI
3332
111 Inc
YI
$49.5M
-2,770
Closed -$74K
YSG
3333
Yatsen Holding
YSG
$881M
-16,720
Closed -$57K
ZEPP
3334
Zepp Health
ZEPP
$718M
-8,100
Closed -$93K
ZVIA icon
3335
Zevia
ZVIA
$193M
-99,199
Closed -$402K
ZVRA icon
3336
Zevra Therapeutics
ZVRA
$502M
-101,793
Closed -$516K
ZYME icon
3337
Zymeworks
ZYME
$1.14B
-36,322
Closed -$254K
LENZ
3338
LENZ Therapeutics
LENZ
$1.2B
-7,744
Closed -$373K
QTTB icon
3339
Q32 Bio
QTTB
$20.4M
-10,977
Closed -$664K
RPT
3340
Rithm Property Trust Inc.
RPT
$121M
-73,402
Closed -$810K
ONIT
3341
Onity Group Inc.
ONIT
$341M
-18,829
Closed -$464K
TECX
3342
Tectonic Therapeutic, Inc. Common Stock
TECX
$314M
-11,492
Closed -$218K
AIFU
3343
AIFU Inc. Class A Ordinary Share
AIFU
$82.9M
-2,025
Closed -$295K
NAGE
3344
Niagen Bioscience, Inc. Common Stock
NAGE
$750M
-762,027
Closed -$1.88M
SPRB
3345
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
-11,643
Closed -$24K
VOXX
3346
DELISTED
VOXX International Corporation Class A
VOXX
-71,659
Closed -$793K
SYRS
3347
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
-18,325
Closed -$202K
BEST
3348
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
-9,490
Closed -$122K
OMGA
3349
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
-31,685
Closed -$219K
VIRX
3350
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
-143,473
Closed -$475K